UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 228

Sortiert nach

ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients

Annals of oncology, 2015-07, Vol.26 (7), p.1353-1362

2015

Link zum Volltext

Verfügbarkeit prüfen

ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients

Annals of oncology, 2018-02, Vol.29 (2), p.523-523

2018

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin

Annals of oncology, 2005-04, Vol.16 (4), p.602-610

2005

Link zum Volltext

Verfügbarkeit prüfen

Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer : Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1

Annals of oncology, 2001, Vol.12 (1), p.59-67

2001

Link zum Volltext

Verfügbarkeit prüfen

134P PROGNOSTIC FACTORS FOR SURVIVAL IN ADULT PATIENTS (PTS) WITH METASTATIC NON-SMALL CELL LUNG CANCER AFTER THE FIRST-LINE CHEMOTHERAPY

Lung cancer (Amsterdam, Netherlands), 2009, Vol.64, p.S56-S57

2009

Link zum Volltext

Verfügbarkeit prüfen

Cost of Questionnaire-Based Process to Identify Occupational Exposures Among Patients with Lung Cancer

Value in health, 2015-11, Vol.18 (7), p.A485-A485

2015

Link zum Volltext

Verfügbarkeit prüfen

PCN308 - Cost of Questionnaire-Based Process to Identify Occupational Exposures Among Patients with Lung Cancer

Value in health, 2015-11, Vol.18 (7), p.A485-A485

2015

Link zum Volltext

Verfügbarkeit prüfen

Multicentric phase II study of cisplatin and etoposide in patients with metastatic carcinoma of unknown primary

American journal of clinical oncology, 2000-12, Vol.23 (6), p.614-616

2000

Link zum Volltext

Verfügbarkeit prüfen

ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4 super(+) lymphocyte count in lymphopenic metastatic breast cancer patients

Annals of oncology, 2015-07, Vol.26 (7), p.1353-1362

2015

Link zum Volltext

Verfügbarkeit prüfen

A phase I II study of 4 monthly courses of high-dose cyclophosphamide and thiotepa for metastatic breast cancer patients

British journal of cancer, 2002-11, Vol.87 (10), p.1079-1085

2002

Link zum Volltext

Verfügbarkeit prüfen

Prospective cohort study of quality of care (QC) and quality of life (QL) of palliative cancer patients in three different situations: In-patient hospitalization (IN), palliative care unit (PA) and home care (HO). Final analysis

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.20670-20670

2008

Link zum Volltext

Verfügbarkeit prüfen

Quality of final care for terminal cancer patients in a comprehensive cancer centre from the point of view of patients' families

Supportive care in cancer, 1996-05, Vol.4 (3), p.163-168

1996

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Navelbine and Fluorouracil as Second-Line Chemotherapy in Metastatic Breast Carcinoma

Oncology, 1998-01, Vol.55 (1), p.87-88

1998

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors for survival in adult patients (pts) with metastatic cancer (MC) after the first-line chemotherapy

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.9573-9573

2008

Link zum Volltext

Verfügbarkeit prüfen

Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoring

British journal of cancer, 1993-05, Vol.67 (5), p.1136-1141

1993

Link zum Volltext

Verfügbarkeit prüfen

SQUIRE : étude multicentrique randomisée de phase III, en ouvert, évaluant gemcitabine-cisplatine (GC) plus necitumumab versus GC en première ligne de traitement du CBNPC épidermoïde (épi) de stade IV

Revue des maladies respiratoires, 2015-01, Vol.32, p.A43-A44

2015

Link zum Volltext

Verfügbarkeit prüfen

The prognosis of lung cancer: any progress since TNM?

Revue des maladies respiratoires, 2004-02, Vol.21 (1), p.15-18

2004

Link zum Volltext

Verfügbarkeit prüfen

Facteurs pronostiques des cancers bronchiques : des progrès depuis la classification TNM ?

Revue des maladies respiratoires, 2004, Vol.21 (1), p.15-18

2004

Link zum Volltext

Verfügbarkeit prüfen

A phase I antiemetic study of MDL 73,147EF, a novel 5-hydroxytryptamine antagonist in cancer patients receiving emetogenic chemotherapy

Annals of oncology, 1994-07, Vol.5 (6), p.549-551

1994

Link zum Volltext

Verfügbarkeit prüfen

Pretreatment staging evaluation in small cell lung carcinoma. A new approach to medical decision making

Chest, 1992-08, Vol.102 (2), p.497-502

1992

Link zum Volltext

Verfügbarkeit prüfen

FAC (fluorouracil, doxorubicin, cyclophosphamide) as second line chemotherapy in patients with metastatic breast cancer progressing under FEC (fluorouracil, epirubicin, cyclophosphamide) chemotherapy

Annals of oncology, 1994-01, Vol.5 (1), p.95-97

1994

Link zum Volltext

Verfügbarkeit prüfen

Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group Phase II Trial of First-Line Irinotecan in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Cervix

Journal of clinical oncology, 1999-10, Vol.17 (10), p.3136-3142

1999

Link zum Volltext

Verfügbarkeit prüfen

Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2001-08, Vol.33 (2), p.277-287

2001

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study

British journal of clinical pharmacology, 2000-10, Vol.50 (4), p.315-324

2000

Link zum Volltext

Verfügbarkeit prüfen

Massive chemotherapy with autologous bone marrow transplantation in 50 cases of bad prognosis non‐Hodgkin's lymphoma

British journal of haematology, 1985-08, Vol.60 (4), p.599-609

1985

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 228

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(71)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(161)
Female
(63)
Male
(57)
Adult
(55)
Middle Aged
(55)
Science & Technology
(46)
Life Sciences & Biomedicine
(43)
Aged
(41)
Old Medline
(34)
Oncology
(28)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Pharmacology. Drug Treatments
(18)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(16)
Chemotherapy
(16)
Adolescent
(15)
Antineoplastic Agents
(15)
Child
(13)
Prognosis
(11)
Sciences Biologiques Et Medicales
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients

ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients

Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin

Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer : Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1

134P PROGNOSTIC FACTORS FOR SURVIVAL IN ADULT PATIENTS (PTS) WITH METASTATIC NON-SMALL CELL LUNG CANCER AFTER THE FIRST-LINE CHEMOTHERAPY

Cost of Questionnaire-Based Process to Identify Occupational Exposures Among Patients with Lung Cancer

PCN308 - Cost of Questionnaire-Based Process to Identify Occupational Exposures Among Patients with Lung Cancer

Multicentric phase II study of cisplatin and etoposide in patients with metastatic carcinoma of unknown primary

ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4 super(+) lymphocyte count in lymphopenic metastatic breast cancer patients

A phase I II study of 4 monthly courses of high-dose cyclophosphamide and thiotepa for metastatic breast cancer patients

Prospective cohort study of quality of care (QC) and quality of life (QL) of palliative cancer patients in three different situations: In-patient hospitalization (IN), palliative care unit (PA) and home care (HO). Final analysis

Quality of final care for terminal cancer patients in a comprehensive cancer centre from the point of view of patients' families

Phase II Trial of Navelbine and Fluorouracil as Second-Line Chemotherapy in Metastatic Breast Carcinoma

Prognostic factors for survival in adult patients (pts) with metastatic cancer (MC) after the first-line chemotherapy

Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoring

SQUIRE : étude multicentrique randomisée de phase III, en ouvert, évaluant gemcitabine-cisplatine (GC) plus necitumumab versus GC en première ligne de traitement du CBNPC épidermoïde (épi) de stade IV

The prognosis of lung cancer: any progress since TNM?

Facteurs pronostiques des cancers bronchiques : des progrès depuis la classification TNM ?

A phase I antiemetic study of MDL 73,147EF, a novel 5-hydroxytryptamine antagonist in cancer patients receiving emetogenic chemotherapy

Pretreatment staging evaluation in small cell lung carcinoma. A new approach to medical decision making

FAC (fluorouracil, doxorubicin, cyclophosphamide) as second line chemotherapy in patients with metastatic breast cancer progressing under FEC (fluorouracil, epirubicin, cyclophosphamide) chemotherapy

Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group Phase II Trial of First-Line Irinotecan in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Cervix

Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancer

Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study

Massive chemotherapy with autologous bone marrow transplantation in 50 cases of bad prognosis non‐Hodgkin's lymphoma

Suchergebnisse filtern